Guru Fundamental Report for ISRG

Validea's guru fundamental report indicates that Intuitive Surgical (ISRG) receives a 71% rating based on their Benjamin Graham-inspired Value Investor model, which favors stocks with low price-to-book and price-to-earnings ratios, low debt, and strong long-term earnings growth; while ISRG passes the model's tests for sales, current ratio, debt, and EPS growth, it fails the P/E and P/B ratio criteria.

Analysis

Intuitive Surgical Inc. (ISRG) receives a 71% rating from Validea's Value Investor model, which is based on Benjamin Graham's deep value principles emphasizing low price-to-book (P/B) and price-to-earnings (P/E) ratios, low debt, and solid long-term earnings growth. While ISRG, a large-cap growth stock in the Medical Equipment & Supplies industry, successfully meets the model's criteria for sales, current ratio, low long-term debt relative to net current assets, and long-term EPS growth, it fails on the crucial valuation metrics of P/E ratio and P/B ratio. This 71% score is below Validea's 80% threshold, which typically indicates that the strategy has 'some interest' in a stock, suggesting a lukewarm endorsement from this specific value-centric model. The mixed outcome, with strong operational fundamentals but unfavorable valuation multiples, aligns with the provided 'mixed' general sentiment score of -0.05, although the per-ticker sentiment for ISRG is slightly positive at 0.25.

Key Decisions for Investors

• Investors should recognize that while Intuitive Surgical demonstrates robust underlying business fundamentals, including positive sales trends, a healthy current ratio, manageable debt, and strong earnings growth, its current valuation does not align with traditional Benjamin Graham value criteria.
• The failure to meet the P/E and P/B ratio tests, resulting in a 71% score on this specific value model, suggests that value-oriented investors might find the stock expensive, despite its operational strengths.
• Consider that ISRG's classification as a 'large-cap growth stock' may explain its higher valuation multiples; therefore, investors should weigh its growth prospects against the valuation concerns highlighted by this Graham-based analysis before making investment decisions.